Another solid quarter with SEK 3 bn net sales, 23% adjusted EBITDA margin

Q3 net sales were stable year over year at SEK 2,988 million, but declined 2% in constant currencies. Adjusted EBITDA rose 3% to SEK 693 million, with the margin unchanged at 23%; reported EBITDA increased to SEK 688 million from SEK 590 million and EBIT to SEK 318 million from SEK 232 million. Net income was SEK 149 million versus SEK 39 million, adjusted net income was SEK 431 million versus SEK 361 million, and operating cash flow was SEK 431 million versus SEK 382 million.

Analysis

Stable reported sales mask modest underlying contraction: constant-currency organic sales fell 2%, while user-acquisition spend rose 4% on the same basis. That divergence raises the risk that growth is being purchased rather than earned through stronger retention, pricing, or product demand. Adjusted EBITDA growth of 3% with a flat 23% margin suggests spend has not yet produced visible operating leverage. The near-term question is whether the higher acquisition investment converts into durable bookings and lifetime value over the next few quarters; if not, management may need to cut spend, trading growth for earnings.

Reported earnings improved more sharply than adjusted EBITDA, but the gap between net income and adjusted net income is material. Without the reconciliation, investors should not treat the headline net-income increase as a clean run-rate signal. Operating cash flow rose but remains below adjusted EBITDA, so cash conversion and working-capital movements merit scrutiny.

Over 1–3 months, the key catalysts are evidence of improved organic bookings, payback on acquisition cohorts, and a reconciliation of reported versus adjusted earnings. Over 6–18 months, persistently elevated acquisition intensity without better growth or margins would imply structurally weaker returns on marketing capital. The company is not identified in the supplied mapping, and there is no valuation or guidance context; avoid inferring a ticker or forcing a directional position. The mildly positive earnings read may be undercut if investors focus on underlying sales contraction and acquisition efficiency.

Key Decisions for Investors

• No immediate directional trade: company identity, valuation, guidance, and share-price reaction are not supplied. Confirm these before sizing exposure.
• Watch the next results for organic bookings or revenue growth relative to constant-currency acquisition spend, plus cohort payback/retention data. If spend continues to outpace growth without improving margins, treat that as a bearish deterioration in marketing returns.
• Request the bridge from reported to adjusted net income and EBITDA, and track operating cash flow conversion. A reversal in cash generation or recurring adjustments would weaken the quality-of-earnings case.
• Falsify the cautious view if organic growth accelerates while acquisition intensity stabilizes or falls and adjusted margins expand; that would indicate improving monetization and operating leverage.